Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Lemaitre Vascular (LMAT) Return on Sales (2016 - 2025)

Historic Return on Sales for Lemaitre Vascular (LMAT) over the last 17 years, with Q3 2025 value amounting to 0.28%.

  • Lemaitre Vascular's Return on Sales rose 800.0% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.2% for FY2024, which is 400.0% up from last year.
  • As of Q3 2025, Lemaitre Vascular's Return on Sales stood at 0.28%, which was up 800.0% from 0.21% recorded in Q2 2025.
  • In the past 5 years, Lemaitre Vascular's Return on Sales ranged from a high of 0.28% in Q3 2025 and a low of 0.08% during Q2 2022
  • Over the past 5 years, Lemaitre Vascular's median Return on Sales value was 0.17% (recorded in 2021), while the average stood at 0.17%.
  • Its Return on Sales has fluctuated over the past 5 years, first plummeted by -1200bps in 2022, then skyrocketed by 800bps in 2023.
  • Over the past 5 years, Lemaitre Vascular's Return on Sales (Quarter) stood at 0.16% in 2021, then dropped by -15bps to 0.13% in 2022, then surged by 30bps to 0.17% in 2023, then rose by 11bps to 0.19% in 2024, then skyrocketed by 48bps to 0.28% in 2025.
  • Its Return on Sales stands at 0.28% for Q3 2025, versus 0.21% for Q2 2025 and 0.18% for Q1 2025.